• 1
    Agostoni A, Cicardi M. Replacement therapy in hereditary and acquired angioedema. Pharmacol Res 1992;26(Suppl 2):148149.
  • 2
    Davis AE III. C1 inhibitor and hereditary angioneurotic edema. Annu Rev Immunol 1988;6:595628.
  • 3
    Cicardi M, Johnson DT. Hereditary and acquired complement component 1 esterase inhibitor deficiency: a review for the hematologist. Acta Haematol 2012;127:208220.
  • 4
    Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005;139:379394.
  • 5
    Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, Bouillet J et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004;114(Suppl 3):S51S131.
  • 6
    Davis AE III, Bissler JJ, Aulak KS. Genetic defects in the C1 inhibitor gene. Complement Today 1993;1:133150.
  • 7
    Davis AE III. The pathogenesis of hereditary angioedema. Transfus Apher Sci 2003;29:195203.
  • 8
    Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 2001;161:24172429.
  • 9
    Bowen T, Cicardi M, Bork K, Zuraw B, Frank M, Ritchie B et al. Hereditary angioedema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 2008;100(1 Suppl 2):S30S40.
  • 10
    Bork K, Hardt J, Schicketanz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 2003;163:12291235.
  • 11
    Farkas H, Harmat G, Füst G, Varga L, Visy B. Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol 2002;13:153161.
  • 12
    Winnewisser J, Rossi M, Späth P, Bürgi H. Type I hereditary angio-oedema. Variability of clinical presentation and course within two large kindreds. J Intern Med 1997;241:3946.
  • 13
    Farkas H, Szongoth M, Bély M, Varga L, Fekete B, Karádi I et al. Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis. Acta Derm Venereol 2001;81:298300.
  • 14
    Visy B, Füst G, Bygum A, Bork K, Longhurst H, Bucher C et al. Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema. Helicobacter 2007;12:251257.
  • 15
    Bouillet L, Longhurst H, Boccon-Gibod I, Bork K, Bucher C, Bygum A et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol 2008;199:484.
  • 16
    Craig TJ, Levy RJ, Wasserman RL, Bewtra AK, Hurewitz D, Obtulowicz K et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 2009;124:801808.
  • 17
    Craig TJ, Bewtra AK, Bahna SL, Hurewitz D, Schneider LC, Levy RJ et al. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks – final results of the I.M.P.A.C.T.2 study. Allergy 2011;66:16041611.
  • 18
    Zuraw BL, Busse PJ, White M, Jacobs J, Lumry W, Baker J et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 2010;363:513522.
  • 19
    Zuraw B, Cicardi M, Levy RJ, Nuijens JH, Relan A, Visscher S et al. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. J Allergy Clin Immunol 2010;126:821827.
  • 20
    Cicardi M, Banerji A, Bracho F, Malbrán A, Rosenkranz B, Riedl M et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 2010;363:532541.
  • 21
    Bork K, Hardt J, Staubach-Renz P, Witzke G. Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:5864.
  • 22
    Lumry W. Pre-procedural administration of nanofiltered C1 esterase inhibitor (Human) (CINRYZE®) for the prevention of hereditary angioedema (HAE) attacks after medical, dental, or surgical procedures. American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting 2011 19–22 March 2011, San Francisco, USA. Abstract 903.
  • 23
    Grant JA, White MV, Li HH, Fitts D, Kalfus IN, Uknis ME et al. Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks. Allergy Asthma Proc 2012;33:348353.
  • 24
    Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010;6:24.
  • 25
    Johnston DT. Diagnosis and management of hereditary angioedema. J Am Osteopath Assoc 2011;111:2836.
  • 26
    Longhurst H, Cicardi M. Hereditary angio-oedema. Lancet 2012;379:474481.